News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,868 Results
Type
Article (26337)
Company Profile (60)
Press Release (367469)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104385)
Career Advice (455)
Deals (16888)
Drug Delivery (53)
Drug Development (47760)
Employer Resources (47)
FDA (12351)
Job Trends (8482)
News (186374)
Policy (19525)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1758)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26825)
ALS (95)
Alzheimer's disease (973)
Antibody-drug conjugate (ADC) (161)
Approvals (12684)
Artificial intelligence (303)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (415)
Cancer (3065)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42964)
Collaboration (849)
Compensation (273)
Complete response letters (16)
COVID-19 (1553)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4230)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3712)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (124)
Earnings (38631)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54203)
Executive appointments (584)
FDA (14628)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (751)
Gene editing (75)
Generative AI (20)
Gene therapy (259)
GLP-1 (541)
Government (3143)
Grass and pollen (4)
Guidances (229)
Healthcare (12213)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (68)
Infectious disease (1684)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7072)
IRA (23)
Job creations (1845)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3646)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (251)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13297)
Medtech (13342)
Mergers & acquisitions (10327)
Metabolic disorders (751)
Multiple sclerosis (97)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1689)
NextGen: Class of 2026 (3933)
Non-profit (2836)
Now hiring (33)
Obesity (311)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (350)
Peanut (42)
People (35635)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12351)
Phase 2 (18583)
Phase 3 (15269)
Pipeline (3037)
Policy (125)
Postmarket research (1668)
Preclinical (3798)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (178)
Rare diseases (426)
Real estate (2869)
Recruiting (18)
Regulatory (15688)
Reports (18)
Research institute (1653)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2133)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (502)
Venture capital (27)
Weight loss (210)
Women's health (54)
Worklife (4)
Date
Today (17)
Last 7 days (304)
Last 30 days (1053)
Last 365 days (16146)
2026 (1488)
2025 (16475)
2024 (19876)
2023 (22754)
2022 (30692)
2021 (32994)
2020 (32194)
2019 (28414)
2018 (21815)
2017 (18910)
2016 (18111)
2015 (21197)
2014 (16025)
2013 (13241)
2012 (14352)
2011 (14623)
2010 (13181)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25486)
Australia (4029)
California (5574)
Canada (1904)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49877)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (578)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3745)
Michigan (149)
Minnesota (443)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1923)
New Mexico (10)
New York (1565)
North Carolina (811)
North Dakota (4)
Northern California (2650)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1348)
Puerto Rico (11)
Rhode Island (35)
South America (523)
South Carolina (59)
Southern California (2235)
Tennessee (124)
Texas (1019)
United States (21621)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
393,868 Results for "crh medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Deals
CRH Medical Securityholders Approve Acquisition by WELL Health
CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) (“CRH” or the “Company”) today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. (“WELL Health”) at the special meeting of CRH securityholders today.
April 16, 2021
·
4 min read
Deals
WELL Health Completes Acquisition of CRH Medical
WELL Health Technologies Corp. (TSX: WELL) (“WELL”), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, and CRH Medical Corporation (“CRH”) are pleased to announce the successful completion of their previously-announced business combination today, pursuant to which WELL has acquired all of the issued and outstanding common shares of CRH
April 22, 2021
·
13 min read
CRH Medical Corporation Announces Startup Joint Venture
VANCOUVER, BC, March 11, 2021 /PRNewswire/ - CRH Medical Corporation announces a startup joint venture where CRH owns a 51% interest in a gastroenterology anesthesia practice located in Largo, Florida.
March 11, 2021
·
5 min read
Press Releases
Intricon becomes Forj Medical and Announces Opening Plans for its Advanced Manufacturing Facility in Costa Rica
Intricon completes construction of its Evolution Free Zone location, combines with Minnetronix Medical, and will fly the Forj Medical flag at its new site; equipment and workforce move into place for the grand opening
December 9, 2025
·
1 min read
Deals
WELL Health Provides an Update on its Proposed Acquisition of CRH Medical
CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021 . The transaction is expected to be completed on or about April 22, 2021 and represents WELL’s largest acquisition to date with a total transaction value of approximately US$369.2 million .
April 19, 2021
·
7 min read
Press Releases
Seno Medical’s Next-Generation Imagio® Imaging System Obtains European Union (EU) Medical Device Regulation (MDR) CE Mark Certification
January 29, 2026
·
3 min read
Press Releases
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
October 31, 2025
·
3 min read
Business
CRH Medical Corporation Announces 2020 Third Quarter Results
CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (“CRH” or the “Company”), today announced financial and operating results for the three months ended September 30, 2020.
November 12, 2020
·
20 min read
Deals
WELL’s CRH Medical Acquires Majority Stake in Two Anesthesia Practices
WELL Health Technologies Corp. is pleased to announce its wholly owned subsidiary, CRH Medical Corporation, has completed two accretive transactions whereby the company has acquired a 51% stake in Northern Indiana Anesthesia Associates, LLC and an add-on practice in Bradenton, Florida which will be part of CRH affiliate, FDHS Anesthesia, LLC.
May 27, 2021
·
6 min read
1 of 39,387
Next